249 related articles for article (PubMed ID: 2316211)
1. Red cell alloantibodies in patients with thalassemia.
Spanos T; Karageorga M; Ladis V; Peristeri J; Hatziliami A; Kattamis C
Vox Sang; 1990; 58(1):50-5. PubMed ID: 2316211
[TBL] [Abstract][Full Text] [Related]
2. Red cell alloantibodies in patients with haemoglobinopathies.
Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
[TBL] [Abstract][Full Text] [Related]
3. RBC alloimmunization and double alloantibodies in thalassemic patients.
Azarkeivan A; Ahmadi MH; Zolfaghari S; Shaiegan M; Ferdowsi S; Rezaei N; Lotfi P
Hematology; 2015 May; 20(4):223-7. PubMed ID: 25130935
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
Jariwala K; Mishra K; Ghosh K
Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
[TBL] [Abstract][Full Text] [Related]
5. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.
Azarkeivan A; Ansari S; Ahmadi MH; Hajibeigy B; Maghsudlu M; Nasizadeh S; Shaigan M; Toolabi A; Salahmand M
Pediatr Hematol Oncol; 2011 Sep; 28(6):479-85. PubMed ID: 21854216
[TBL] [Abstract][Full Text] [Related]
6. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors.
El Kababi S; Benajiba M; El Khalfi B; Hachim J; Soukri A
Transfus Clin Biol; 2019 Nov; 26(4):240-248. PubMed ID: 31279519
[TBL] [Abstract][Full Text] [Related]
8. The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital.
Romphruk AV; Simtong P; Butryojantho C; Pimphumee R; Junta N; Srichai S; Komvilaisak P; Puapairoj C
Transfusion; 2019 Jan; 59(1):177-184. PubMed ID: 30443908
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
[TBL] [Abstract][Full Text] [Related]
10. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
[TBL] [Abstract][Full Text] [Related]
11. Red cell immunization in multiply transfused Malay thalassemic patients.
Noor Haslina MN; Ariffin N; Illuni Hayati I; Rosline H
Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):1015-20. PubMed ID: 17333748
[TBL] [Abstract][Full Text] [Related]
12. Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes.
Michail-Merianou V; Pamphili-Panousopoulou L; Piperi-Lowes L; Pelegrinis E; Karaklis A
Vox Sang; 1987; 52(1-2):95-8. PubMed ID: 3300026
[TBL] [Abstract][Full Text] [Related]
13. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent.
Singer ST; Wu V; Mignacca R; Kuypers FA; Morel P; Vichinsky EP
Blood; 2000 Nov; 96(10):3369-73. PubMed ID: 11071629
[TBL] [Abstract][Full Text] [Related]
14. [Red blood cell immunization in haemoglobinopathie: about 84 cases].
Ben Amor I; Louati N; Khemekhem H; Dhieb A; Rekik H; Mdhaffar M; Gargouri J
Transfus Clin Biol; 2012 Dec; 19(6):345-52. PubMed ID: 23103424
[TBL] [Abstract][Full Text] [Related]
15. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.
Abdelrazik AM; Elshafie SM; El Said MN; Ezzat Ahmed GM; Al-Gamil AK; El Nahhas MG; Sady AA
Transfusion; 2016 Sep; 56(9):2303-7. PubMed ID: 27351342
[TBL] [Abstract][Full Text] [Related]
16. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
[TBL] [Abstract][Full Text] [Related]
17. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
Ang AL; Lim CY; Ng WY; Lam JCM
Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773
[TBL] [Abstract][Full Text] [Related]
18. Alloimmunisation in thalassaemics: a comparison between recipients of usual matched and partial better matched blood. An evaluation at a tertiary care centre in India.
Pujani M; Pahuja S; Dhingra B; Chandra J; Jain M
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s100-4. PubMed ID: 23399366
[TBL] [Abstract][Full Text] [Related]
19. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients.
Saied DA; Kaddah AM; Badr Eldin RM; Mohaseb SS
J Pediatr Hematol Oncol; 2011 Aug; 33(6):409-14. PubMed ID: 21792035
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq.
Al-Mousawi MM; Al-Allawi NA; Alnaqshabandi R
Hemoglobin; 2015; 39(6):423-6. PubMed ID: 26327166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]